Key facts
- It has raised $12.0M; the latest was Later Stage VC in Aug 2025.
- Notable investors include Tech Incubator Program for Startup, D-Camp, Kakao Ventures, Murex Partners, Pavilion Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for JNPMEDI
- ·The full record, as it builds
Funding rounds
No funding rounds for JNPMEDI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About JNPMEDI
Developer of a medical data platform designed to perform clinical research and trial operations. The company specializes in clinical cloud alternatives that digitally transform the capabilities of regulatory authorities, pharmaceuticals, and clinical research organizations, enabling healthcare professionals to execute, manage, monitor, and audit clinical trials.
- Sector
- Healthcare
- HQ
- Incheon, South Korea
- Founded
- 2020
- Employees
- 153
- Website
- jnpmedi.com/
- Ownership
- Privately Held (backing)
JNPMEDI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in JNPMEDI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on JNPMEDI in its N-PORT filings yet. We sweep new filings monthly.